No results for ‘’
GKB Ophthalmics Ltd
₹64.79
(0.46%)
Tue, 15 Sept 2026, 11:00 am
Health Technology
Medical Specialties
24.5KGKB Ophthalmics Enterprise Value (EV)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 79.59 | 4.45 | 0 | 3.03 | 5000 | 6.94 | 21.40 | 0 | 0 | 0 | 0 | 36.39 | 0 | 0 | 0 |
| Price to book ratio | 0 | 0 | 0.97 | 0.39 | 0.22 | 0.30 | 0.52 | 0.61 | 1.19 | 1.08 | 0.79 | 0.37 | 0.66 | 0.74 | 0.88 | 0.74 | 0.59 |
| Price to sales ratio | 0 | 0 | 0.64 | 0.36 | 0.18 | 0.29 | 0.59 | 0.63 | 0.75 | 0.62 | 0.75 | 0.37 | 0.73 | 0.65 | 0.73 | 0.50 | 0.28 |
| Price to cash flow ratio | 0 | 0 | 24.68 | 7.78 | 8.42 | 2.74 | 3.95 | 0 | 0 | 0 | 17.29 | 11.75 | 0 | 12.39 | 0 | 10.50 | 0 |
| Enterprise value | 0 | 0 | 25.67Cr | 25.56Cr | 20.22Cr | 22.21Cr | 26.1Cr | 24.86Cr | 56.24Cr | 55.2Cr | 46.97Cr | 22.96Cr | 39.35Cr | 46.05Cr | 56.08Cr | 42.05Cr | 35.49Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 28.96 | 3.83 | 6.46 | 2.93 | 29.21 | 0 | 29.90 | 40.37 | 41.06 | 10.86 | 20.87 | 9.43 | 15.41 | 72.61 | 0 |
| Debt to equity ratio | 0.51 | 0.51 | 0.65 | 0.39 | 0.44 | 0.32 | 0.22 | 0.16 | 0.15 | 0.22 | 0.26 | 0.26 | 0.19 | 0.19 | 0.18 | 0.19 | 0.28 |
| Return on equity % | 0 | 7.35 | 1.23 | 11.87 | -1.77 | 10.73 | 0.01 | 9.37 | 5.68 | -2.13 | -2.22 | -3.24 | -1.49 | 2.03 | -0.27 | -4.61 | -12.65 |
GKB Ophthalmics Ltd Enterprise Value
The GKB Ophthalmics Ltd Enterprise Value is a key financial metric used by investors to evaluate GKB Ophthalmics Ltd's valuation, profitability, and overall financial performance. Tracking the GKB Ophthalmics Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
GKB Ophthalmics Ltd (NSE: GKB, BSE: 533212) is currently trading at ₹64.79, with a market capitalization of ₹32.11Cr. As a leading company in the Health technology sector and Medical specialties industry, monitoring the GKB Ophthalmics Ltd Enterprise Value is essential for fundamental analysis.
GKB Ophthalmics Ltd Enterprise Value Current Value
The current GKB Ophthalmics Ltd Enterprise Value stands at 35.49Cr.
The GKB Ophthalmics Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
GKB Ophthalmics Ltd Enterprise Value Historical Trend
The GKB Ophthalmics Ltd Enterprise Value has shown the following historical trend:
- 2024: 35.49Cr
- 2023: 42.05Cr
- 2022: 56.08Cr
- 2021: 46.05Cr
- 2020: 39.35Cr
The decline in GKB Ophthalmics Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What GKB Ophthalmics Ltd Enterprise Value Indicates for Investors
The GKB Ophthalmics Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of GKB Ophthalmics Ltd.
GKB Ophthalmics Ltd Enterprise Value Analysis Summary
The GKB Ophthalmics Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking GKB Ophthalmics Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of GKB Ophthalmics Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.